---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-23-057737"
form_type: "8-K"
ticker: "BRKR"
cik: "0001109354"
company_name: "BRUKER CORP"
filed_at: "2023-11-02T23:59:59+00:00"
generated_at: "2026-06-08T23:21:48.216914+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Bruker Q3: Rev $742.8M, Non-GAAP EPS $0.74, FY organic guidance raised to 11.5-12.5%

## Summary
- Q3 revenue $742.8M (+16.3% YoY); organic +10.9%, acquisitions +2.1%, FX +3.3%.
- Q3 GAAP EPS $0.60; Non-GAAP EPS $0.74 (+12.1% YoY).
- BSI segment revenue $676.3M (+16.1% YoY); BEST segment $70.6M (+19.1%).
- FY 2023 revenue guidance raised to $2.88-$2.91B; organic growth 11.5-12.5% (+150 bps midpoint).
- Cellular Analysis (PhenomeX) acquired Oct 2; slightly dilutive in FY24, accretive by FY26.

## SEC filing metadata
- accession: 0000950170-23-057737
- form_type: 8-K
- ticker: BRKR
- cik: 0001109354
- company_name: BRUKER CORP
- filed_at: 2023-11-02T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1109354/000095017023057737/0000950170-23-057737-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1109354/000095017023057737/brkr-20231102.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-23-057737
- JSON: https://secwatch.observer/filing/0000950170-23-057737.json
- Plain text: https://secwatch.observer/filing/0000950170-23-057737.txt

## Key facts
- Earnings Releases
  BRUKER CORP reported the third quarter ended September 30, 2023 results: revenue $742.8 million, EPS $0.60 GAAP diluted EPS; $0.74 non-GAAP diluted EPS. Guidance raised.
  - Period: the third quarter ended September 30, 2023
  - Revenue: $742.8 million
  - EPS: $0.60 GAAP diluted EPS; $0.74 non-GAAP diluted EPS
  - Guidance: raised
  - Result: reported results
  source text: Bruker Reports Third Quarter 2023 Financial Results • Q3 2023 revenues of $742.8 million, up 16.3% year-over-year (yoy); organic revenue up 10.9% yoy • Q3 2023 GAAP EPS $0.60; non-GAAP EPS $0.74, up 12.1% yoy • Bruker increases FY 2023 revenue guidance to $2.88-$2.91 billion
  evidence_url: https://www.sec.gov/Archives/edgar/data/1109354/000095017023057737/0000950170-23-057737-index.htm
- Earnings Releases
  BRUKER CORP reported the first nine months ended September 30, 2023 results: revenue $2.11 billion, EPS $1.50 GAAP diluted EPS; $1.88 non-GAAP diluted EPS. Guidance raised.
  - Period: the first nine months ended September 30, 2023
  - Revenue: $2.11 billion
  - EPS: $1.50 GAAP diluted EPS; $1.88 non-GAAP diluted EPS
  - Guidance: raised
  - Result: reported results
  source text: First Nine Months of 2023 Financial Results For the first nine months of 2023, Bruker’s revenues were $2.11 billion, an increase of 15.8% from $1.82 billion in the first nine months of 2022.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1109354/000095017023057737/0000950170-23-057737-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.